e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients
Heitmann J., Ehlenz K., Penzel T., Becker H.F., Grote L., Voigt K.H., Hermann Peter J., Vogelmeier C.
Source:
Eur Respir J 2004; 23: 255-262
Journal Issue:
February
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Heitmann J., Ehlenz K., Penzel T., Becker H.F., Grote L., Voigt K.H., Hermann Peter J., Vogelmeier C.. Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 2004; 23: 255-262
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Cardiac sympathovagal balance during sleep in obstructive sleep apnea patients is different under auto-adjusting CPAP than fixed-CPAP treatment
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006
Ventilatory support and pharmacological treatment of patients with central apnoea or hypoventilation during sleep
Source: Eur Respir Rev 2007; 16: 115-124
Year: 2007
Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP
Source: Eur Respir J 2006; 27: 128-135
Year: 2006
Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006
CPAP and measures of cardiovascular risk in males with OSAS
Source: Eur Respir J 2008; 32: 1488-1496
Year: 2008
Impact of CPAP treatment on sympathetic activity and renin-angiotensin-aldosterone system in normotensive men with obstructive sleep apnoea
Source: Eur Respir J 2006; 28: Suppl. 50, 294s
Year: 2006
Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005
Recommendations for the management of patients with obstructive sleep apnoea and hypertension
Source: Eur Respir J 2013; 41: 523-538
Year: 2013
Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012
Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Wrist-actigraphic estimation of sleep time under nCPAP treatment in sleep apnoea patients
Source: Eur Respir J 2004; 23: 891-895
Year: 2004
Serotonin in obstructive sleep apnea patients with before and after the continuous positive airway pressure treatment
Source: Annual Congress 2005 - Upper airway interventions in OSA patients
Year: 2005
Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients
Source: Eur Respir J 2009; 34: 694
Year: 2009
Adherence to positive airway pressure in non-sleepy patients with obstructive sleep apnoea
Source: Eur Respir J 2013; 42: 863-866
Year: 2013
Efficacy of an automatic positive airway pressure system for treatment of obstructive sleep apnoea
Source: Eur Respir J 2002; 20: Suppl. 38, 9s
Year: 2002
Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke
Source: Eur Respir J 2001; 18: 623-629
Year: 2001
Blood pressure responsiveness to obstructive events during sleep after chronic CPAP
Source: Eur Respir J 2003; 21: 509-514
Year: 2003
Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
Long-term continuous positive airway pressure compliance in females with obstructive sleep apnoea
Source: Eur Respir J 2013; 42: 1255-1262
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept